Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Global X Education ETF stock logo
EDUT
Global X Education ETF
$20.54
$20.54
$18.40
▼
$25.52
$2.67M0.87477 shsN/A
MCSE
Martin Currie Sustainable International Equity ETF
$13.83
$13.83
$13.24
▼
$15.07
$4.42M1.1612,506 shsN/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
$37.88
$37.23
$30.90
▼
$38.04
$3.03M1.15928 shsN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
$7.38
$7.38
$5.87
▼
$11.83
$2.21M0.923,034 shsN/A
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Global X Education ETF stock logo
EDUT
Global X Education ETF
0.00%0.00%0.00%0.00%0.00%
MCSE
Martin Currie Sustainable International Equity ETF
0.00%0.00%0.00%0.00%-1.75%
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
0.00%0.00%0.00%0.00%+10.42%
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Global X Education ETF stock logo
EDUT
Global X Education ETF
$20.54
$20.54
$18.40
▼
$25.52
$2.67M0.87477 shsN/A
MCSE
Martin Currie Sustainable International Equity ETF
$13.83
$13.83
$13.24
▼
$15.07
$4.42M1.1612,506 shsN/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
$37.88
$37.23
$30.90
▼
$38.04
$3.03M1.15928 shsN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
$7.38
$7.38
$5.87
▼
$11.83
$2.21M0.923,034 shsN/A
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Global X Education ETF stock logo
EDUT
Global X Education ETF
0.00%0.00%0.00%0.00%0.00%
MCSE
Martin Currie Sustainable International Equity ETF
0.00%0.00%0.00%0.00%-1.75%
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
0.00%0.00%0.00%0.00%+10.42%
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Global X Education ETF stock logo
EDUT
Global X Education ETF
2.42
Hold$20.54N/A
MCSE
Martin Currie Sustainable International Equity ETF
2.70
Moderate Buy$13.83N/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
2.83
Moderate Buy$37.88N/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Global X Education ETF stock logo
EDUT
Global X Education ETF
N/AN/AN/AN/AN/AN/A
MCSE
Martin Currie Sustainable International Equity ETF
N/AN/AN/AN/AN/AN/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
N/AN/AN/AN/AN/AN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Global X Education ETF stock logo
EDUT
Global X Education ETF
N/AN/A27.61N/AN/AN/AN/AN/AN/A
MCSE
Martin Currie Sustainable International Equity ETF
N/AN/A31.77N/AN/AN/AN/AN/AN/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
N/AN/A31.50N/AN/AN/AN/AN/AN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/AN/A17.02N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Global X Education ETF stock logo
EDUT
Global X Education ETF
$0.271.31%N/AN/AN/A
MCSE
Martin Currie Sustainable International Equity ETF
$0.080.58%N/AN/AN/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
$0.320.84%N/AN/AN/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A0.12%N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Global X Education ETF stock logo
EDUT
Global X Education ETF
N/A
MCSE
Martin Currie Sustainable International Equity ETF
N/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
N/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A

Insider Ownership

CompanyInsider Ownership
Global X Education ETF stock logo
EDUT
Global X Education ETF
N/A
MCSE
Martin Currie Sustainable International Equity ETF
N/A
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
N/A
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Global X Education ETF stock logo
EDUT
Global X Education ETF
147,000130,000N/ANot Optionable
MCSE
Martin Currie Sustainable International Equity ETF
N/A320,000N/ANot Optionable
NZUS
SPDR MSCI USA Climate Paris Aligned ETF
N/A80,000N/AOptionable
Kelly CRISPR & Gene Editing Technology ETF stock logo
XDNA
Kelly CRISPR & Gene Editing Technology ETF
N/A300,000N/AOptionable

Recent News About These Companies

Cathie Wood buys the dip in gene-editing firm CRISPR Therapeutics
March 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4563025-cathie-wood-buys-the-dip-in-gene-editing-firm-crispr-therapeutics
CRISPR unlocks a new way to defeat resistant lung cancer
November 17, 2025  |  sciencedaily.comS
CRISPR breakthrough reverses chemotherapy resistance in lung cancer
November 17, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/crispr-breakthrough-reverses-chemotherapy-resistance-in-lung-cancer/ar-AA1QBwUK
CRISPR Therapeutics Reports Q3 2025 Financial Results
November 12, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/crispr-therapeutics-reports-q3-2025-financial-results/ar-AA1QgMMp
Investment Guide to Genetics Stocks and ETFs
August 28, 2025  |  nai500.comN
CHOP, Penn advance CRISPR gene editing with fast-developed treatment for an infant with a rare disease
May 15, 2025  |  msn.comhttps://www.msn.com/en-us/science/biology/chop-penn-advance-crispr-gene-editing-with-fast-developed-treatment-for-an-infant-with-a-rare-disease/ar-AA1EQMQr
Nobel Prize winners convince court to revive CRISPR patent dispute
May 12, 2025  |  reuters.comhttps://www.reuters.com/legal/government/nobel-prize-winners-convince-court-revive-crispr-patent-dispute-2025-05-12/
Biotech investors: Stop expecting CRISPR science to make big leaps
April 14, 2025  |  statnews.comS
AI and gene editing promise ‘bespoke proteins’ for biotech
October 8, 2024  |  siliconrepublic.comS
Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
October 2, 2024  |  yahoo.comhttps://www.yahoo.com/tech/weight-loss-drug-breakthroughs-gene-090000589.html
K-12 Genome Editing at Only $2 a Pop
September 27, 2024  |  yahoo.comhttps://www.yahoo.com/tech/k-12-genome-editing-only-144035108.html
Vertex Stock: Came For CF Drugs, Staying For Gene Therapy
August 2, 2024  |  seekingalpha.comhttps://seekingalpha.com/article/4709620-vertex-stock-came-for-cf-drugs-staying-for-gene-therapy
CRISPR can treat common form of inherited blindness, early data hint
May 15, 2024  |  msn.comhttps://www.msn.com/en-gb/health/other/crispr-can-treat-common-form-of-inherited-blindness-early-data-hint/ar-BB1mrQQG
CRISPR gene editing: in summary
March 27, 2024  |  biotechniques.comB
Intellia Collaborates With ReCode To Develop Gene Therapy For Cystic Fibrosis
February 15, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/intellia-collaborates-with-recode-to-develop-gene-therapy-for-cystic-fibrosis-1033071688
CRISPR Technology: Unveiling the Breakthrough in Gene Editing and Its Far-Reaching Implications
January 18, 2024  |  techbullion.comT
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year
January 15, 2024  |  msn.comhttps://www.msn.com/en-us/money/other/here-s-why-crispr-therapeutics-stock-rose-54-last-year/ar-AA1n1jau
Gene editing is now a medical reality
December 8, 2023  |  news.yahoo.comhttps://news.yahoo.com/gene-editing-now-medical-reality-224326223.html
FDA approves first use of CRISPR gene editing to treat sickle cell disease
December 8, 2023  |  news.yahoo.comhttps://news.yahoo.com/fda-approves-first-crispr-gene-173254689.html
FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder
December 8, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/fda-approves-first-gene-editing-cell-therapy-for-sickle-cell-disease-an-inherited-blood-disorder-1032886628

Media Sentiment Over Time

Global X Education ETF stock logo

Global X Education ETF NASDAQ:EDUT

$20.54 0.00 (0.00%)
As of 09/9/2026

The Global X Education ETF (EDUT) is an exchange-traded fund that is based on the Indxx Global Education Thematic index, a market-cap-weighted index of global companies providing products and services that facilitate education. EDUT was launched on Jul 10, 2020 and is managed by Global X.

Martin Currie Sustainable International Equity ETF NASDAQ:MCSE

$13.82 0.00 (0.00%)
As of 09/9/2026

The Martin Currie Sustainable International Equity ETF (MCSE) is an exchange-traded fund that is based on the MSCI AC World ex USA index. The fund actively invests in a concentrated equity portfolio of foreign companies of any market capitalization. The fund selects equities based on ESG criteria and factors related to long-term potential. MCSE was launched on Nov 30, 2015 and is managed by Franklin Templeton.

SPDR MSCI USA Climate Paris Aligned ETF NASDAQ:NZUS

The SPDR MSCI USA Climate Paris Aligned ETF (NZUS) is an exchange-traded fund that is based on the MSCI USA Climate Paris Aligned index. The fund tracks a tier-weighted index of large- and mid-cap US stocks selected and weighted based on ESG criteria that are compatible with the Paris Climate Agreement and carbon reduction goals. NZUS was launched on Apr 21, 2022 and is managed by State Street.

Kelly CRISPR & Gene Editing Technology ETF stock logo

Kelly CRISPR & Gene Editing Technology ETF NASDAQ:XDNA

$7.38 0.00 (0.00%)
As of 09/9/2026

The Strategic CRISPR & Gene Editing Technology ETF (XDNA) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market-cap-weighted index of companies in developed markets that focus on the advancements in DNA modification technology. XDNA was launched on Jan 12, 2022 and is managed by Kelly.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas